Annals ofMetabolic Syndrome

Volume: 1 - Number: 2 - July 15, 2005

Outstanding

Diabetes, Insulin Resistance, and the Metabolic Syndrome in Patients With Acute Myocardial Infarction Without Previously Known Diabetes

The Metabolic Syndrome and Antioxidant Concentrations: Findings From the Third National Health and Nutrition Examination Survey

Carotid Atherosclerosis and Coronary Heart Disease in the Metabolic Syndrome: Prospective data from the Bruneck Study

A Comparison of the Prevalence of the Metabolic Syndrome Using Two Proposed Definitions

Feature Article

Low Insulin Sensitivity (Si = 0) in Diabetic and Nondiabetic Subjects in the Insulin Resistance Atherosclerosis Study: Is it associated with components of the metabolic syndrome and nontraditional risk factors?

Diabetes, Insulin Resistance, and the Metabolic Syndrome in Patients With Acute Myocardial Infarction Without Previously Known Diabetes

The Metabolic Syndrome and Antioxidant Concentrations: Findings From the Third National Health and Nutrition Examination Survey

Prevalence and Characteristics of the Metabolic Syndrome in the San Antonio Heart and Framingham Offspring Studies

Higher Offspring Birth Weight Predicts the Metabolic Syndrome in Mothers but Not Fathers 8 Years After Delivery: The Pune Children’s Study

Long-Term, Randomized Clinical Trial of Two Diets in the Metabolic Syndrome and Type 2 Diabetes

Cardiorespiratory Fitness and Vigorous Leisure-Time Physical Activity Modify the Association of Small Size at Birth With the Metabolic Syndrome

Prevalence of the Metabolic Syndrome Among Omani Adults

Two-Hour Insulin Determination Improves the Ability of Abdominal Fat Measurement to Identify Risk for the Metabolic Syndrome

NCEP-Defined Metabolic Syndrome, Diabetes, and Prevalence of Coronary Heart Disease Among NHANES III Participants Age 50 Years and Older

Analysis of the Agreement Between the World Health Organization Criteria and the National Cholesterol Education Program-III Definition of the Metabolic Syndrome: Results from a population-based survey

Human Metabolic Syndrome Resulting From Dominant-Negative Mutations in the Nuclear Receptor Peroxisome Proliferator-Activated Receptor-

Carotid Atherosclerosis and Coronary Heart Disease in the Metabolic Syndrome: Prospective data from the Bruneck Study

Differential Regulation of Lipoprotein Kinetics by Atorvastatin and Fenofibrate in Subjects With the Metabolic Syndrome

Insulin Resistance, the Metabolic Syndrome, and Risk of Incident Cardiovascular Disease in Nondiabetic American Indians: The Strong Heart Study

A Comparison of the Prevalence of the Metabolic Syndrome Using Two Proposed Definitions

High Prevalence of Insulin Resistance and Metabolic Syndrome in Overweight/Obese Preadolescent Hong Kong Chinese Children Aged 9–12 Years

The ACE Insertion/Deletion Polymorphism Is Not Associated With the Metabolic Syndrome (WHO Definition) in Brazilian Type 2 Diabetic Patients

Prospective Study of C-Reactive Protein in Relation to the Development of Diabetes and Metabolic Syndrome in the Mexico City Diabetes Study

Components of the Metabolic Syndrome and Risk of Cardiovascular Disease and Diabetes in Beaver Dam

Components of the "Metabolic Syndrome" and Incidence of Type 2 Diabetes

Treatment With Dietary trans10cis12 Conjugated Linoleic Acid Causes Isomer-Specific Insulin Resistance in Obese Men With the Metabolic Syndrome

Low Levels of Leisure-Time Physical Activity and Cardiorespiratory Fitness Predict Development of the Metabolic Syndrome

Total Sialic Acid and Associated Elements of the Metabolic Syndrome in Women With and Without Previous Gestational Diabetes

Factor Analysis of Metabolic Syndrome Using Directly Measured Insulin Sensitivity: The Insulin Resistance Atherosclerosis Study

Prevalence of Metabolic Syndrome Among HIV Patients

Preobesity in World Health Organization Classification Involves the Metabolic Syndrome in Japanese

Metabolic Syndrome in American Indians

ACE Gene Insertion/Deletion Polymorphism Associated With 1998 World Health Organization Definition of Metabolic Syndrome in Chinese Type 2 Diabetic Patients

Low Production Capacity of Interleukin-10 Associates With the Metabolic Syndrome and Type 2 Diabetes : The Leiden 85-Plus Study

A Tailored Therapy for the Metabolic Syndrome : The Dual Peroxisome Proliferator-Activated Receptor-/ Agonist LY465608 Ameliorates Insulin Resistance and Diabetic Hyperglycemia While Improving Cardiovascular Risk Factors in Preclinical Models

Increased Glucocorticoid Receptor Expression in Human Skeletal Muscle Cells May Contribute to the Pathogenesis of the Metabolic Syndrome

Type 2 Diabetes and Metabolic Syndrome in Filipina-American Women : A high-risk nonobese population